Merck KGaA Teams With Saturnus Bio to Build Precision Cardiology Portfolio for Rare Genetic Cardiomyopathies Merck KGaA, Darmstadt, Germany has entered a strategic research-stage collaboration with Saturnus Bio, a biotechnology company founded by Versant Ventures, in a move aimed at…
Vyriad Reshapes Executive Leadership Team as It Prepares for Next Phase of Growth in In Vivo CAR T and Viral Delivery Therapies Vyriad, Inc., a clinical-stage biotechnology company focused on developing targeted genetic therapies for cancer and other serious diseases,…
Arrowhead Pharmaceuticals Wins EU Approval for REDEMPLO® to Lower Triglycerides in Adults with Familial Chylomicronemia Syndrome Arrowhead Pharmaceuticals has secured an important regulatory milestone in Europe with the European Commission’s marketing authorization of REDEMPLO® (plozasiran) for adults living with familial…
Trace Neuroscience Launches Global Clinical Development Program for TRCN-1023 in ALS Trace Neuroscience, Inc., a biopharmaceutical company focused on advancing genomic medicine for people living with neurodegenerative diseases, has announced the start of its global clinical development program for TRCN-1023,…
Syntax Bio and Ajinomoto Health & Nutrition North America Partner to Evaluate StemFit™ Media for Next-Generation Cell Therapy Workflows Syntax Bio, a synthetic biology company focused on programming the next generation of cell therapies, has entered into a collaboration with…
Syntax Bio Expands Series A to $14.4 Million, Strengthens Leadership Team and Advances Cell Programming Platform for Type 1 Diabetes Therapies Syntax Bio, a synthetic biology company focused on programming the next generation of cell therapies, has announced a significant…
Incyte Japan Secures Approval for Minjuvi Combo in Relapsed or Refractory DLBCL Incyte Biosciences Japan G.K. has secured a significant regulatory milestone in Japan with the approval of Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adult patients…
Neuron23 Secures $2.5 Million Grant from The Michael J. Fox Foundation to Expand Precision Medicine Parkinson’s Trial into Israel Neuron23 Inc., a clinical-stage biotechnology company focused on advancing precision medicine approaches for Parkinson’s disease, has received a $2.5 million grant…
Deciphera Pharmaceuticals Launches Global Phase 3 INTREPID Trial of Sapablursen for Polycythemia Vera Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd., has announced a significant milestone in the development of a potential new treatment for polycythemia vera (PV), with…
Jazz Pharmaceuticals and AbCellera Partner to Advance Next-Generation T-Cell Engaging Antibodies for Gastrointestinal and Solid Tumors Jazz Pharmaceuticals and AbCellera have entered into a strategic research collaboration aimed at discovering and developing a new generation of T-cell engaging (TCE) multispecific…
Senopsys Celebrates 20 Years of Advancing Patient-Friendly Medicines Through Sensory Science Senopsys, a company recognized for its expertise in sensory science and pharmaceutical palatability solutions, is marking its 20th anniversary of serving the global biopharmaceutical industry. Over the past two…
Fujifilm and HORIBA Co-Develop High-Sensitivity Inline Raman Measurement System to Advance Biopharmaceutical Manufacturing FUJIFILM Corporation and HORIBA, Ltd. have announced the joint development of a high-sensitivity inline Raman measurement system designed to provide continuous, real-time monitoring of critical manufacturing parameters…